What is Minoxidil and How Does It Work?
Minoxidil was originally developed in the 1970s as a blood pressure medication. During clinical use, doctors discovered a surprising side effect: increased hair growth. [1] This discovery led to the development of topical minoxidil for androgenetic alopecia, first for men and later for women. [1] Today, minoxidil is available in two forms: as a topical solution or foam for scalp application and as a tablet for oral intake.
Minoxidil promotes hair growth through several biological mechanisms. The medication dilates blood vessels and thereby improves scalp circulation, allowing hair follicles to be better supplied with oxygen, nutrients, and growth factors. [1] Additionally, minoxidil stimulates the formation of new blood vessels and shortens the resting phase of hairs while extending the growth phase. [1] This makes hairs grow longer and thicker. This mechanism also explains initial shedding in the first weeks, as old, thin hairs fall out to make room for new, stronger hairs. Studies in mice and in human dermal papilla cells also show that minoxidil activates a signaling pathway in the hair roots that can extend the growth phase. [3]
Topical Minoxidil
Topical minoxidil is available as an over-the-counter solution or foam and is applied directly to the scalp. In Switzerland, several products with 2% and 5% are approved and available in pharmacies. [8] [10]
Efficacy depends on whether your scalp has enough of a specific enzyme. This enzyme converts minoxidil into its active form and is called sulfotransferase (SULT1A1). It is located in the hair follicles. [4]
The activity of this enzyme varies greatly between individuals. People with low enzyme activity in the scalp respond less well to topical minoxidil. [4] In addition, according to the professional information for a 5% minoxidil product, on average only 1.7 percent of the applied minoxidil reaches the bloodstream. [10]
Solution or Foam?
The original solution often contains propylene glycol, which can cause skin irritation. The foam formulation is propylene glycol-free and is significantly better tolerated, especially for sensitive skin. [1] The foam also dries faster and is easier to apply.
In women, once-daily 5% foam was equivalent to twice-daily 2% solution in a randomized trial and was better tolerated. [13] A phase III trial of 322 women did not meet its prespecified noninferiority criterion; both treatments increased hair count by about 24 hairs per cm² at 24 weeks. [14]
Dosage and Application Frequency
In women, a randomized trial showed that once-daily application of 5 percent minoxidil foam can achieve comparable improvements to twice-daily application of the 2 percent solution. [13] Depending on the product, medicinal product information may specify once- or twice-daily use. As one example, the professional information for a 5% minoxidil product lists 1 ml twice daily and a maximum daily amount of 2 ml. [10] The actual frequency depends on the package leaflet or physician instructions.
Which Concentration is Right?
| Concentration | Efficacy | Tolerability | Context |
|---|---|---|---|
| 2% | Moderate | Very Good | Approved topical concentration; use according to product |
| 5% | High | Good | Well-studied topical concentration; use according to product |
| 10 % | Not superior to 5% in one study [12] | More irritation than 5% [12] | Individual prescription; medical benefit-risk assessment |
Comparison of Minoxidil Concentrations for Topical Application [2]
5 percent minoxidil is well studied and available in Switzerland as a topical product. In a 48-week randomized study in men, 5 percent minoxidil produced about 45 percent more hair regrowth than 2 percent minoxidil; both concentrations were superior to placebo. [2] Local irritation was more common with 5 percent.
Higher concentrations may be prescribed as individually compounded preparations. Evidence for additional benefit is mixed, while local side effects may increase. [12] A physician should set the concentration and application schedule.
Oral Minoxidil
Oral minoxidil is increasingly being used to treat hair loss. In Switzerland, it is not officially approved for this use and is therefore prescribed off-label by physicians. When taken orally, it is absorbed through the gastrointestinal tract and converted to its active form in the liver. [5] [9]
The activating enzyme is present in large amounts in the liver. This means orally taken minoxidil is activated differently than topical minoxidil on the scalp. In studies, oral minoxidil is discussed among other things for people who do not respond sufficiently to topical products. [5] [9]
Dosage and Efficacy
A retrospective study of low-dose oral minoxidil in men with androgenetic alopecia reports hair regrowth during treatment. [5] These data are relevant but do not replace an individual benefit-risk assessment.
Low-dose oral minoxidil has also been studied in women. In a large retrospective study of 1,404 patients (943 of them women), increased hair growth was the most frequent side effect at 15.1 percent. [21]
A 2025 double-blind randomized trial in men with androgenetic alopecia compared 2.5 mg with 5 mg daily over 24 weeks. After 24 weeks, there was no significant difference in hair density between both groups. [11] Which dose is appropriate must be determined by a physician.
Topical or Oral?
Topical minoxidil is available in Switzerland without prescription and acts mostly locally. Oral minoxidil is not approved for hair loss and is only an option as physician-supervised off-label use. We do not currently prescribe oral minoxidil through orva.
What to Expect Over Time
Understanding typical milestones during minoxidil treatment helps set realistic expectations and prevent premature discontinuation.
In the first 2 to 6 weeks, a temporary increase in hair loss can occur. [10] This effect is explained by minoxidil accelerating the transition of hair follicles from the resting phase to the growth phase, so that older, thin hairs fall out. If increased shedding lasts longer than 6 weeks, the professional information advises stopping and consulting a physician. [10]
According to the professional information for a 5% minoxidil product, first results can be expected after 2 to 4 months of twice-daily use; onset and degree of response vary individually. [10]
How many users notice an improvement depends on the population, the product and how response is measured. In a Cochrane review of women with female pattern hair loss, six pooled randomised trials showed that 157 of 593 women using minoxidil (mostly 2%) reported a moderate to marked increase in hair regrowth, about 26 percent. With placebo, it was 77 of 555, about 14 percent. [16] In men, participants in the 48-week study by Olsen et al. rated their scalp coverage and the benefit of treatment significantly better with 5 percent than with 2 percent or placebo. [2]
In the 48-week study by Olsen et al., the response occurred earlier with 5 percent than with 2 percent minoxidil. [2] If there is no improvement after 4 months, the professional information for a 5% minoxidil product states that treatment should be stopped. [10] Whether additional therapies such as microneedling, retinoids or antiandrogens are an option should be assessed by a physician.
Continuous treatment is needed to maintain regrowth. [10]
Putting Application Instructions in Context
The exact amount, frequency, and contact time depend on the package leaflet or prescription. For a 5% product, hair and scalp should be completely dry before application; hands are washed thoroughly before and after application. The professional information also lists a pipette or dosing pump as application systems and 6 pump sprays for 1 ml of solution. [10]
For oral minoxidil, low-dose off-label regimens exist in studies. Dose, timing, and any increases must be determined and monitored by a physician.
Combination with Other Therapies
Minoxidil's efficacy can be influenced in certain cases by combination with other evidence-based treatments.
Microneedling has been studied in randomized trials as an addition to topical minoxidil. A meta-analysis of randomized trials found a significantly higher hair count with microneedling plus minoxidil than with minoxidil alone (SMD 1.32; 95% confidence interval 0.73 to 1.92), with substantial heterogeneity between studies (I² = 88%). [6]
A randomized pilot study reported an almost fourfold greater increase in hair count (91.4 versus 22.2 hairs per cm²) with weekly microneedling plus 5% minoxidil compared with minoxidil alone after 12 weeks. [15]
Another randomized study over 24 weeks showed in 40 women an effectiveness rate of 85 percent (17 of 20) for the combination of 2% minoxidil and weekly microneedling, compared with 45 percent (9 of 20) with 2% minoxidil alone. Treatment was rated effective if the Sinclair grade improved by at least one step, as judged from photographs by a blinded assessor. [17] In another randomized study of 120 women, blinded photo assessment after 24 weeks showed at least mild improvement in 95 percent with 5% minoxidil plus microneedling every two weeks, compared with 55 percent with 5% minoxidil alone. [18] Both studies were small and included only women in China. Microneedling is a separate procedure. Whether it is an option is decided with a physician.
Microneedling may work because it temporarily opens the scalp barrier. Minoxidil can then penetrate more effectively. [18]
Topical tretinoin (a vitamin A derivative) has been studied together with minoxidil. It can increase the enzyme activity in the scalp that minoxidil needs to work. [7] Tretinoin increases skin permeability [10] and formation of the activating enzyme in hair follicles. [7] Tretinoin is not approved for hair loss. Whether such a combination is an option is a doctor’s decision.
Safety and Side Effects
Topical minoxidil is usually well tolerated. Most side effects are local and mild. The professional information for a 5% minoxidil product lists local reactions such as irritation, flaking, dermatitis, redness and itching as common, meaning in 1 to 10 of 100 people treated. These frequencies come from a randomized study of 393 men. [10] According to the professional information, the excipient propylene glycol can cause localised skin irritation such as contact dermatitis, and the ethanol in the solution can cause irritation and dry skin. [10] Propylene glycol-free foam formulations cause less irritation. [1] True allergic contact dermatitis is rare. In an analysis of 99 cases confirmed by patch testing, minoxidil itself was the responsible allergen in 74.7 percent of those affected and propylene glycol in 17.1 percent. [19]
Increased hair growth outside the application area (hypertrichosis) is listed as very common in the professional information. [10] For women, it reports such hypertrichosis in 37 percent of cases, which is why the 5% solution is not indicated for women. [10] An analysis of placebo-controlled trials with a total of 1,333 women found spontaneous reports of hypertrichosis or facial hair in 4 percent, more often with 5% than with 2% minoxidil. The authors describe the effect as reversible; stopping treatment was not always necessary. [20] These sources do not state how long it takes to resolve.
Important for Oral Minoxidil
At low doses, serious side effects are rare: a large retrospective study of 1,404 patients observed no life-threatening side effects. [21] A review of 17 studies (634 patients) described low-dose oral minoxidil as well tolerated in healthy individuals; larger randomized trials are still needed. [9] Common side effects are increased body hair growth, mild ankle swelling, lightheadedness, and occasional palpitations. With existing heart, kidney, or liver problems, medical supervision is required.
Discontinuing Minoxidil
Discontinuing minoxidil is a significant decision. According to the professional information, regrowth stops after discontinuation and the pre-treatment state is to be expected after 3 or 4 months. [10] A review also describes hair shedding within 3 to 4 months after stopping. [1]
After discontinuation, many users experience renewed hair loss that can last several months. [10] The extent varies. If minoxidil is to be discontinued, this should be discussed with a physician or pharmacist.
Whether other therapies, such as antiandrogens like finasteride for hair loss, are an option in this situation should be assessed by a physician.
Conclusion
Minoxidil remains one of the best-researched treatments for androgenetic alopecia. Topical minoxidil offers a local option with mostly local side effects. Oral minoxidil is not approved for hair loss and should only be used as part of physician-supervised off-label treatment.
Combinations with microneedling, retinoids, or antiandrogen therapies such as finasteride topical vs. oral are discussed in studies, but should be medically assessed.
It is important to have realistic expectations. If you start, plan for a few months before anything shows, and the response varies individually. Minoxidil is a long-term therapy. All gains are lost after discontinuation. [10]
At orva, a Swiss physician can assess whether a topical formulation with minoxidil and other active ingredients is suitable for you. Start with our online consultation so your information can be medically reviewed.
Facts and figures
- 2% and 5% are the strengths of the non-prescription minoxidil products approved in Switzerland. [8] [10]
- 1.7% of the applied minoxidil reaches the bloodstream on average, according to the prescribing information of a 5% product. [10]
- Around 45% more hair growth was seen with 5% than with 2% minoxidil in a 48-week randomised trial in men. [2]
- 26% of women on minoxidil, compared with 14% on placebo, reported a moderate to marked increase in hair growth across six pooled randomised trials. [16]
- In the first 2 to 6 weeks, shedding can temporarily increase. [10]
- 2 to 4 months is how long the prescribing information of a 5% product expects before first results, varying from person to person. [10]
- 3 to 4 months after stopping, hair is expected to return to its starting point. [10]
- 1 to 10 in 100 people treated have local reactions such as irritation, flaking or itching. [10]
- 37% of women using the 5% solution develop hypertrichosis according to the prescribing information, which is why it is not indicated for women. [10]
- 1,404 patients were included in a retrospective multicentre study of low-dose oral minoxidil without a control group, and no life-threatening side effects were observed in it. Oral minoxidil is not approved for hair loss in Switzerland. [21]
Frequently asked questions
Is minoxidil available without a prescription in Switzerland?
Topical minoxidil at 2% and 5% is available in Swiss pharmacies without a prescription as a solution or foam. Higher concentrations are only available as a compounded formulation prescribed by a doctor. Oral minoxidil is not approved for hair loss and is only an option as off-label use under a doctor’s responsibility.
How long does minoxidil take to work?
If you start, plan for several months. The prescribing information of a 5% product mentions 2 to 4 months of regular use before first results, and onset and extent vary from person to person. If there is no improvement after 4 months, it advises stopping.
Is it normal to lose more hair at the start?
Yes, in the first 2 to 6 weeks hair loss can temporarily increase, because older, thin hairs move into the new growth phase more quickly. If the increased shedding lasts longer than 6 weeks, the prescribing information advises stopping and seeking medical advice.
What happens if I stop minoxidil?
New hair growth stops, and according to the prescribing information the starting point is to be expected after 3 to 4 months. Minoxidil is therefore a long-term therapy. It is best to discuss stopping with a doctor or pharmacist.
What side effects does topical minoxidil have?
Mostly local and mild reactions such as irritation, flaking, redness or itching, which the prescribing information lists in 1 to 10 out of 100 people treated. Increased hair growth outside the application area is also common. Foam without propylene glycol is often better tolerated than the classic solution.
Ingredients in this guide
Read more about how each ingredient works, its side effects and the research on the ingredient pages.
References
- [1]Suchonwanit P, Thammarucha S, Leerunyakul K. (2019). Minoxidil and its use in hair disorders: a review. Drug Design, Development and Therapy. doi.org/10.2147/DDDT.S214907
- [2]Olsen EA, Dunlap FE, Funicella T, et al. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology. doi.org/10.1067/mjd.2002.124088
- [3]Kwack MH, Kang BM, Kim MK, et al. (2011). Minoxidil activates β-catenin pathway in human dermal papilla cells: a possible explanation for its anagen prolongation effect. Journal of Dermatological Science. doi.org/10.1016/j.jdermsci.2011.01.013
- [4]Pietrauszka K, Bergler-Czop B. (2020). Sulfotransferase SULT1A1 activity in hair follicle, a prognostic marker of response to the minoxidil treatment in patients with androgenetic alopecia: a review. Advances in Dermatology and Allergology. doi.org/10.5114/ada.2020.99947
- [5]Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, et al. (2019). Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2019.04.054
- [6]Ahmed KMA, Kozaa YA, Abuawwad MT, et al. (2025). Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis. Archives of Dermatological Research. doi.org/10.1007/s00403-025-04032-1
- [7]Sharma A, Goren A, Dhurat R, et al. (2019). Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes. Dermatologic Therapy. doi.org/10.1111/dth.12915
- [8]Swissmedic. (2023). Arzneimittelinformation - Alopexy 2% und 5% Lösung zur Anwendung auf der Haut. Swissmedic Journal 05-2023. swissmedic.ch (Accessed 13.10.2026)
- [9]Randolph M, Tosti A. (2021). Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2020.06.1009
- [10]Pierre Fabre Pharma AG. (2023). Alopexy 5%, Lösung zur Anwendung auf der Haut. Swissmedicinfo. swissmedicinfo.ch (Accessed 13.10.2026)
- [11]Carvalho Fonseca LP, Miot HA, Prescendo Chaves CR, Müller Ramos P. (2025). Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2025.09.031
- [12]Ghonemy S, Alarawi A, Bessar H. (2021). Efficacy and safety of a new 10% topical minoxidil versus 5% topical minoxidil and placebo in the treatment of male androgenetic alopecia: a trichoscopic evaluation. Journal of Dermatological Treatment. doi.org/10.1080/09546634.2019.1654070
- [13]Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. (2011). A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2010.09.724
- [14]Blume-Peytavi U, Shapiro J, Messenger AG, et al. (2016). Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study. Journal of Drugs in Dermatology. pubmed.ncbi.nlm.nih.gov (Accessed 13.10.2026)
- [15]Dhurat R, Sukesh M, Avhad G, et al. (2013). A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. International Journal of Trichology. doi.org/10.4103/0974-7753.114700
- [16]van Zuuren EJ, Fedorowicz Z, Schoones J. (2016). Interventions for female pattern hair loss. Cochrane Database of Systematic Reviews. doi.org/10.1002/14651858.CD007628.pub4
- [17]Zhang Y, Sheng Y, Zeng Y, et al. (2022). Randomized trial of microneedling combined with 2% minoxidil topical solution for the treatment of female pattern hair loss in a Chinese population. Journal of Cosmetic Dermatology. doi.org/10.1111/jocd.15424
- [18]Liang X, Chang Y, Wu H, et al. (2022). Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial. Frontiers in Medicine. doi.org/10.3389/fmed.2022.905140
- [19]Kiratiwongwan R, Boonchai W, Kanokrungsee S. (2024). Allergic Contact Dermatitis to Topical Preparations Containing Minoxidil: A Systematic Review and Individual Participant Data Meta-Analysis. Dermatitis. doi.org/10.1089/derm.2024.0092
- [20]Dawber RPR, Rundegren J. (2003). Hypertrichosis in females applying minoxidil topical solution and in normal controls. Journal of the European Academy of Dermatology and Venereology. doi.org/10.1046/j.1468-3083.2003.00621.x
- [21]Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. (2021). Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology. doi.org/10.1016/j.jaad.2021.02.054
Our guides are based on scientific sources, cited in the text. Learn about our standards
